AVAdriana Nicholson Vest

Adriana Nicholson Vest

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adriana Nicholson Vest has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • CORRELATION BETWEEN LIVE BIRTH AND SERUM ESTRADIOL CONCENTRATION ON THE DAY OF EXOGENOUS PROGESTERONE START IN HORMONE REPLACED SINGLE FROZEN EMBRYO TRANSFER

    by Adriana Nicholson Vest, Papri Sarkar, Rachel Sprague, Jiarui Wang, Luis R. Hoyos, Meike L. Uhler, Michael Vance Homer, Samad Jahandideh, Shayne Plosker, Anthony N. Imudia

  • Open Access

    Strongyloides stercoralis Hyperinfection Syndrome in Pregnancy

    by Allison N. Akers, Adriana Vest, Claudio V. Schenone, Alejandro Rodriguez, Claudio V. Schenone Giugni

    Strongyloidiasis is a parasitic infection with a high global burden of disease. Hyperinfection syndrome is a life-threatening complication that predominantly affects immunosuppressed individuals, such as those receiving corticosteroid treatment. Despite its worldwide prevalence, little is known about the clinical effects of this condition on the feto-maternal dyad during pregnancy. We present a case of placental abruption leading to preterm delivery in a pregnancy complicated by Strongyloides stercoralis hyperinfection syndrome following antenatal corticosteroid use. Although rare, this condition is associated with high mortality rates and adverse pregnancy outcomes. Therefore, screening at-risk individuals may be warranted in pregnancies where antenatal corticosteroid administration is considered.


  • Top Cited Papers

    An open source benchmarked toolbox for cardiovascular waveform and interval analysis

    by Adriana Nicholson Vest, Giulia Da Poian, Qiao Li, Chengyu Liu, Shamim Nemati, Amit J Shah, Gari D Clifford

    Objective : This work aims to validate a set of data processing methods for variability metrics, which hold promise as potential indicators for autonomic function, prediction of adverse cardiovascular outcomes, psychophysiological status, and general wellness. Although the investigation of heart rate variability (HRV) has been prevalent for several decades, the methods used for preprocessing, windowing, and choosing appropriate parameters lacks consensus among academic and clinical investigators. Moreover, many of the important steps are omitted from publications, preventing reproducibility. Approach : To address this, we have compiled a comprehensive and open-source modular toolbox for calculating HRV metrics and other related variability indices, on both raw cardiovascular time series and RR intervals. The software, known as the PhysioNet Cardiovascular Signal Toolbox, is implemented in the MATLAB programming language, with standard (open) input and output formats, and requires no external libraries. The functioning of our software is compared with other widely used and referenced HRV toolboxes to identify important differences. Main results : Our findings demonstrate how modest differences in the approach to HRV analysis can lead to divergent results, a factor that might have contributed to the lack of repeatability of studies and clinical applicability of HRV metrics. Significance : Existing HRV toolboxes do not include standardized preprocessing, signal quality indices (for noisy segment removal), and abnormal rhythm detection and are therefore likely to lead to significant errors in the presence of moderate to high noise or arrhythmias. We therefore describe the inclusion of validated tools to address these issues. We also make recommendations for default values and testing/reporting.


  • Design and Testing of a Transcutaneous RF Recharging System for a Fetal Micropacemaker

    by Adriana N. Vest, Li Zhou, Xuechen Huang, Viktoria Norekyan, Yaniv Bar-Cohen, Ramen H. Chmait, Gerald Eli Loeb

    We have developed a rechargeable fetal micropacemaker in order to treat severe fetal bradycardia with comorbid hydrops fetalis. The necessarily small form factor of the device, small patient population, and fetal anatomy put unique constraints on the design of the recharging system. To overcome these constraints, a custom high power field generator was built and the recharging process was controlled by utilizing pacing rate as a measure of battery state, a feature of the relaxation oscillator used to generate stimuli. The design and in vitro and in vivo verification of the recharging system is presented here, showing successful generation of recharging current in a fetal lamb model.


  • A novel method to estimate safety factor of capture by a fetal micropacemaker

    by Adriana Nicholson Vest, Li Zhou, Yaniv Bar-Cohen, Gerald Eli Loeb

    We have developed a rechargeable fetal micropacemaker in order to treat severe fetal bradycardia with comorbid hydrops fetalis, a life-threatening condition in pre-term non-viable fetuses for which there are no effective treatment options. The small size and minimally invasive form factor of our design limit the volume available for circuitry and a power source. The device employs a fixed-rate and fixed-amplitude relaxation oscillator and a tiny, rechargeable lithium ion power cell. For both research and clinical applications, it is valuable to monitor the electrode-myocardium interface in order to determine that adequate pacemaker output is being provided. This is typically accomplished by observing the minimal stimulus strength that achieves threshold for pacing capture. The output of our simple micropacemaker cannot be programmatically altered to determine this minimal capture threshold, but a safety factor can be inferred by determining the refractory period for ventricular capture at a given stimulus strength. This is done by measuring the minimal timing between naturally occurring QRS complexes and pacing stimuli that successfully generate a premature ventricular contraction. The method was tested in a pilot study in four fetal sheep and the data demonstrate that a relative measure of threshold is obtainable. This method provides valuable real-time information about the electrode-tissue interface.


  • Minimally invasive implantable fetal micropacemaker: mechanical testing and technical refinements

    by Li Zhou, Adriana Nicholson Vest, Raymond A. Peck, Jonathan P. Sredl, Xuechen Huang, Yaniv Bar-Cohen, Michael J. Silka, Jay D. Pruetz, Ramen H. Chmait, Gerald E. Loeb

    This paper discusses the technical and safety requirements for cardiac pacing of a human fetus with heart failure and hydrops fetalis secondary to complete heart block. Engineering strategies to meet specific technical requirements were integrated into a systematic design and implementation consisting of a novel fetal micropacemaker, a percutaneous implantation system, and a sterile package that enables device storage and recharging maintenance in a clinical setting. We further analyzed observed problems on myocardial fixation and pacing lead fatigue previously reported in earlier preclinical trials. This paper describes the technical refinements of the implantable fetal micropacemaker to overcome these challenges. The mechanical performance has been extensively tested to verify the improvement of reliability and safety margins of the implantation system.


  • Preclinical testing and optimization of a novel fetal micropacemaker

    by Yaniv Bar-Cohen, Gerald E. Loeb, Jay D. Pruetz, Michael J. Silka, Catalina Guerra, Adriana N. Vest, Li Zhou, Ramen H. Chmait